{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:28:44Z","timestamp":1781108924972,"version":"3.54.1"},"reference-count":16,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1297\/cpe.26.265","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T18:10:11Z","timestamp":1506535811000},"page":"265-269","source":"Crossref","is-referenced-by-count":0,"title":["Five cases of childhood-onset Graves\u2019 disease treated with either surgery or radio-iodine therapy"],"prefix":"10.1297","volume":"26","author":[{"given":"Kouki","family":"Tomari","sequence":"first","affiliation":[{"name":"Division of General Pediatrics, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Shimada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Yagi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"},{"name":"Division of Endocrinology and Metabolism, Tokyo Metropolitan Children\u2019s Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Muldoon, BT, Mai, VQ, Burch, HB. Management of Graves disease: an overview and comparison of clinical practice guidelines with actual practice trends. Endocrinol Metab Clin North Am 2014;43: 495\u2013516.","DOI":"10.1016\/j.ecl.2014.02.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Burch, HB, Burman, KD, Cooper, DSA. A 2011 survey of clinical practice patterns in the management of Graves disease. J Clin Endocrinol Metab 2012;97: 4549\u201358.","DOI":"10.1210\/jc.2012-2802"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bahn, RS, Burch, HB, Cooper, DS, Garber, JR, Greenlee, MC, Klein, I, et al. American Thyroid AssociationAmerican Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011;17: 456\u2013520.","DOI":"10.4158\/EP.17.3.456"},{"key":"4","unstructured":"4. Sinha, CK, Decoppi, P, Pierro, A, Brain, C, Hindmarsh, P, Butler, G, et al. Thyroid Surgery in Children: Clinical Outcomes. Eur J Pediatr Surg 2015;25: 425\u20139."},{"key":"5","unstructured":"5. Rivkees, SA, Sklar, C, Freemark, M. Clinical review 99: The management of Graves disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83: 3767\u201376."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Laurberg, P, Berman, DC, Andersen, S, B\u00fclow Pedersen, I. Sustained control of Graves hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves orbitopathy. Thyroid 2011;21: 951\u20136.","DOI":"10.1089\/thy.2011.0039"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Peters, H, Fischer, C, Bogner, U, Reiners, C, Schleusener, H. Treatment of Graves hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997;7: 247\u201351.","DOI":"10.1089\/thy.1997.7.247"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rivkees, SA, Szarfman, A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 2010;95: 3260\u20137.","DOI":"10.1210\/jc.2009-2546"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Glaser, NS, Styne, DM, Organization of Pediatric Endocrinologists of Northern California Collaborative Graves Disease Study Group. Predicting the likelihood of remission in children with Graves disease: a prospective, multicenter study. Pediatrics 2008;121: e481\u20138.","DOI":"10.1542\/peds.2007-1535"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gastaldi, R, Poggi, E, Mussa, A, Weber, G, Vigone, MC, Salerno, M, et al. Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers. J Pediatr 2014;164: 1189\u201394.e1.","DOI":"10.1016\/j.jpeds.2013.12.047"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Franklyn, JA, Boelaert, K. Thyrotoxicosis. Lancet 2012;379: 1155\u201366.","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Smith, J, Brown, RS. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves disease treated using antithyroid medication. Thyroid 2007;17: 1103\u20137.","DOI":"10.1089\/thy.2007.0072"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Abraham, P, Avenell, A, McGeoch, SC, Clark, LF, Bevan, JS. Antithyroid drug regimen for treating Graves hyperthyroidism. Cochrane Database Syst Rev 2010; CD003420.","DOI":"10.1002\/14651858.CD003420.pub4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Werner, SC. The thyroid. a fundamental and clinical text. Am J Med Sci 1956;232: 476.","DOI":"10.1097\/00000441-195610000-00020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Minamitani, K, Sato, H, Ohye, H, Harada, S, Arisaka, O, Committee on Pharmaceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Disease Committee, Japan Thyroid Association (Taskforce for the Revision of the Guidelines for the Treatment of Childhood-Onset Graves Disease). Guidelines for the treatment of childhood-onset Graves\u2019 disease in Japan. Clin Pediatr Endocrinol 2017;26: 29\u201362.","DOI":"10.1297\/cpe.26.29"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Read, CH, Tansey, MJ, Menda, Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves patients. J Clin Endocrinol Metab 2004;89: 4229\u201333.","DOI":"10.1210\/jc.2003-031223"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/4\/26_2017-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T21:25:48Z","timestamp":1570137948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/4\/26_2017-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.26.265","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}